The company's pci | bridgeTM enhances supply chain visibility and reduces time spent on manual activities such as forecasting, inventory management, reporting, supplier management and document sharing.
Stephan Von Schilcher, global strategic account manager at Systech, discusses the repercussions of counterfeit drug epidemic on patients and what pharma companies must to combat the problem.
Tower Cold Chain has launched a sustainability hub for customers, highlighting how its consultative, pragmatic approach to pharmaceutical cold chain requirements can help to minimise waste and deliver improved sustainability.
Alcura, a provider of specialised clinical trial services and a part of Cencora, has been granted a Manufacturing and Importation Authorization (MIA) license for cell and gene therapies (CGT) by the Spanish Agency of Medicines and Medical Devices.
Stephan Von Schilcher, global strategic account manager at Systech explores mapping the counterfeit and diversion epidemic in the pharmaceutical industry for out latest EPM Online Insight.
Kerry Pickstone discusses the impact of the new anti-espionage laws in China, weighing how Western pharmaceutical firms can embed resilience into their supply chain strategies and mitigate potential disruption.
Around 2,000 people attended the 2024 edition of LogiPharma, the annual leading life sciences and supply chain event, making it the largest to date – with 70 percent of exhibition booths already booked for 2025.
Magrietha Mallinson, Global Vertical Lead, Health at DP World discusses unlocking the potential of Africa's pharmaceutical market in our latest EPM Online insight.
Dr. Danial Arkwell, Head of Global Key Accounts, Pharma at Envirotainer highlights the vital role of efficient logistics in getting orphan drugs to patients in desperate need.
